Abstract
Probiotics and prebiotics are viable bacteria with beneficial effects on the host and components that selectively act on the beneficial commensal bacteria, respectively. The combined use of probiotics and prebiotics is termed synbiotics. Probiotic intake improves dysbiosis in the intestinal microbiota and can positively affect canine atopic dermatitis (CAD). However, clinical studies on improvements in CAD using synbiotics remain limited.
In this study, 15 dogs with CAD who received prednisolone, a synthetic glucocorticoid (GC) used in the treatment of CAD, for more than 90 days were continuously treated with Lactobacillus paracasei M-1 from fermented food as a probiotic, and trisaccharide kestose as a prebiotic, for 90 days to determine their synbiotic effects on CAD. The CAD symptoms were evaluated using the canine atopic dermatitis lesion index (CADLI) and pruritus visual analog scores (PVAS) at 30, 60 and 90 days after synbiotic administration. The total prednisolone use for 90 days pre- and post-administration was also evaluated.
Synbiotic administration significantly reduced the CADLI (pre: median, 28.0 [22.0-32.0]; 30 days: median, 20.0 [20.0−28.0]; 60 days: median, 20.0 [10.0−21.0]; 90 days: median, 12.0 [10.0-19.0]) and PVAS (pre: median, 6.0 [5.0-7.0]; 30 days: median, 3.0 [3.0-3.5]; 60 days: median, 3.0 [3.0-3.5]; 90 days: median, 2.0 [2.0-3.5]) scores, and reduced the total prednisone use over 90 days (pre: 112.0 [25-450] mg; post: 80.0 [18.-300.0] mg; p<0.001) in the 15 dogs. Thus, the synbiotic activity of L. paracasei M-1 and trisaccharide kestose can improve CAD.
Go to article
Bibliography
References:
Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 17: 687-701.
Chang YS, Trivedi MK, Jha A, Lin YF, Dimaano L, García-Romero MT (2016) Synbiotics for Prevention and Treatment of Atopic Dermati-tis: A Meta-analysis of Randomized Clinical Trials. JAMA Pediatr 70: 236-242.
Craig JM (2016) Atopic dermatitis and the intestinal micro-biota in humans and dogs. Vet Med Sci 2: 95-105.
D’Auria E, Panelli S, Lunardon L, Pajoro M, Paradiso L, Beretta S, Loretelli C, Tosi D, Perini M, Bedogni G, Abdelsalam A, Fiorina P, Bandi C, Zuccotti GV (2021) Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double-blind, placebo-controlled trial. Pharmacol Res 163: 105284.
Endo A, Nakamura S, Konishi K, Nakagawa J, Tochio T (2016) Variations in prebiotic oligosaccharide fermentation by intestinal lactic acid bacteria. Int J Food Sci Nutr 67: 125-132.
Favrot C, Steffan J, Seewald W, Picco F (2010) A prospective study on the clinical features of chronic canine atopic dermatitis and its diagno-sis. Vet Dermatol 21: 23-31.
Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regula-tory T cells. Nature 504: 446-450.
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14: 491-502.
Guidi EE, Gramenzi A, Persico P, Di Prinzio R, Di Simone D, Cornegliani L (2021) Effects of feeding a hypoallergenic diet with a nutraceu-tical on fecal dysbiosis index and clinical manifestations of canine atopic dermatitis. Animals (Basel) 11: 2985.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. The International Scientific Association for Pro-biotics and Prebiotics consensus statement on the scope and ap-propriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11: 506-514.
Ide K, Shinohara M, Yamagishi S, Endo A, Nishifuji K, Tochio T (2020) Kestose supplementation exerts bifidogenic effect within fecal mi-crobiota and increa-ses fecal butyrate concentration in dogs. J Vet Med Sci 82: 1-8.
Japanese Ministry of Health, Labor and Welfare Good Clinical Practice. Ministry of Health, Labor and Welfare Ministerial Ordinance, No. 28 dated March 27 (1997) and No. 24 dated February 29 (2008) Tokyo, Japan.
Kim H, Rather IA, Kim H, Kim S, Kim T, Jang J, Seo J, Lim J, Park YH (2015) A Double-Blind, Placebo Controlled-Trial of a Probiotic Strain Lactobacillus sakei Probio-65 for the Prevention of Canine Atopic Dermatitis. J Microbiol Biotechnol 25: 1966-1969.
Kim WK, Jang YJ, Han DH, Jeon K, Lee C, Han HS, Ko G (2020) Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota. Gut Microbes 12: 1-14.
Ohshima-Terada Y, Higuchi Y, Kumagai T, Hagihara A, Nagata M (2015) Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis. Vet Dermatol 26: 350.
Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, Prélaud P (2010) Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol 21: 233.
Orlando A, Refolo MG, Messa C, Amati L, Lavermicocca P, Guerra V, Russo F (2012) Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus para-casei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer 64: 1103-1111.
Plant JD, Gortel K, Kovalik M, Polissar NL, Neradilek MB (2012) Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis. Vet Dermatol 23: 515-e103.
Rybnícek J, Lau-Gillard PJ, Harvey R, Hill PB (2009) Further validation of a pruritus severity scale for use in dogs. Vet Dermatol 20: 115-122.
Saridomichelakis MN, Olivry T (2016) An update on the treatment of canine atopic dermatitis. Vet J 207: 29-37.
Shibata R, Kimura M, Takahashi H, Mikami K, Aiba Y, Takeda H, Koga Y (2009) Clinical effects of kestose, a prebiotic oligosaccharide, on the treatment of atopic dermatitis in infants. Clin Exp Allergy 39: 1397-1403.
Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, Sanders ME (2020) The International Scientific
Szczepanik MP, Popiel J, Cekiera A, Pomorska-Handwerker D, Karaś-Tęcza J, Ściskalska M, Oczkowska K, Taube M, Olender V, Parys P (2020) Evaluation of the clinical efficiency of lokivetmab in client privately owned atopic dogs – multicenter study. Pol J Vet Sci 23: 191-195.
Tochio T, Kadota Y, Tanaka T, Koga Y (2018) 1-Kestose, the Smallest Fructooligosaccharide Component, Which Efficiently Stimulates Fae-calibacterium prausnitzii as Well as Bifidobacteria in Humans. Foods 7: 140.
Tochio T, Kitaura Y, Nakamura S, Sugawa C, Takahashi M, Endo A, Shimomura Y (2016) An alteration in the cecal microbiota composition by feeding of 1-kestose results in a marked increase in the cecal butyrate content in rats. PLoS One 11: e0166850.
Go to article
en
pl
